GreenRoc now on the EU radar after presentation on Amitsoq at the Greenland Business Mission. Watch the interview here.

Less Ads, More Data, More Tools Register for FREE
Sponsored Content
Sponsored Content

Pin to quick picksVerici Dx Regulatory News (VRCI)

Share Price Information for Verici Dx (VRCI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.45
Bid: 6.00
Ask: 6.90
Change: 0.00 (0.00%)
Spread: 0.90 (15.00%)
Open: 6.45
High: 6.45
Low: 6.45
Prev. Close: 6.45

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Second Price Monitoring Extn

28 Mar 2023 09:05

RNS Number : 4540U
Verici Dx PLC
28 March 2023
 

Second Price Monitoring Extension

A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes.

London Stock Exchange electronic order book users have a final opportunity to review the prices and sizes of orders entered in this security prior to the auction execution.

The applicable percentage is set by reference to a security's Millennium Exchange sector. This is set out in the Sector Breakdown tab of the Parameters document at www.londonstockexchange.com/tradingservices

Service notice: Due to low readership of PME notices, RNS will cease their publication in late March / early April 2023. Please contact rns@lseg.com if you have any questions related to this change.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APMUWRWROVUOURR
Date   Source Headline
21st Mar 20234:35 pmRNSPrice Monitoring Extension
13th Mar 20237:00 amRNSStatement re. Silicon Valley Bank
9th Mar 20237:00 amRNSTwo key patents granted in the US
2nd Mar 20237:00 amRNSCLIA Certificate of Compliance
27th Feb 20232:00 pmRNSPrice Monitoring Extension
7th Dec 20227:00 amRNSDirector/PDMR Shareholding
1st Dec 20226:07 pmRNSCorrection: Holding(s) in Company
3rd Oct 20227:00 amRNSProduct rebranding as Tutivia™
7th Sep 20227:00 amRNSHalf-year Report
6th Sep 20227:00 amRNSPositive results for Clarava from validation study
5th Sep 20227:00 amRNSNotice of Results
2nd Sep 20224:41 pmRNSSecond Price Monitoring Extn
2nd Sep 20224:35 pmRNSPrice Monitoring Extension
27th Jun 20223:17 pmRNSResult of AGM and voting results
24th Jun 20227:00 amRNSHolding(s) in Company
20th Jun 20227:30 amRNSDistribution of Verici Dx shares by EKF
16th Jun 20227:00 amRNSInvestor Presentation
15th Jun 202210:57 amRNSCEO Video Interview
14th Jun 20229:00 amRNSFurther data from Tuteva™ validation study
9th Jun 20227:00 amRNSCommercial Team Appointments
25th May 202212:00 pmRNSPosting of Annual Report & Accounts
19th May 20227:00 amRNSFinal Results
12th May 20227:00 amRNSResults of Tuteva™ clinical validation study
1st Apr 20227:00 amRNSClinical Validation Study Update
23rd Mar 20226:12 pmRNSHolding(s) in Company
21st Mar 20227:00 amRNSHolding(s) in Company
18th Mar 20225:13 pmRNSHolding(s) in Company
16th Mar 20223:33 pmRNSHolding(s) in Company
15th Mar 20224:34 pmRNSHolding(s) in Company
11th Mar 20229:30 amRNSClose of Subscription and Fundraise Update
4th Mar 20224:13 pmRNSResult of Fundraise
4th Mar 202212:20 pmRNSClose of Accelerated Bookbuild
4th Mar 20227:10 amRNSProposed Fundraise
15th Feb 20227:00 amRNSSuccessful completion of analytical validation
26th Jan 20224:28 pmRNSNet Asset Value(s)
14th Jan 20227:00 amRNSInvestor Presentation
12th Jan 20222:00 pmRNSProgress and strategy update
6th Jan 20227:00 amRNSClarava™ and Tuteva™ complete testing requirements
5th Jan 20227:00 amRNSCollaboration with Illumina
4th Jan 20227:00 amRNSGrant of two CPT Codes by AMA
17th Dec 20211:19 pmRNSHolding(s) in Company
8th Nov 20217:00 amRNSLaunch of Barbara T. Murphy Endowed Lectureship
1st Nov 20217:00 amRNSLaunch of Career Development Research Grant
13th Sep 20217:01 amRNSLorenzo Gallon, MD, Appointed as Chair of S.A.B
13th Sep 20217:00 amRNSHalf-year Report
31st Aug 20217:00 amRNSPatient enrolment completed
19th Aug 20217:00 amRNSAppointment of Non-executive Director
27th Jul 20217:00 amRNSAcceptance to CLIA Program
20th Jul 20217:00 amRNSFirst European Clinical Trial Site Initiated
1st Jul 20214:56 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Make Better Investment Decisions

Register for FREE

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.